Choledochoscope-assisted percutaneous fibrin glue sealing of bile leak complicating transarterial chemoembolization of hepatocellular carcinoma after liver transplantation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Choledochoscope-assisted percutaneous fibrin glue sealing of bile leak complicating transarterial chemoembolization of hepatocellular carcinoma after liver transplantation ; volume:43 ; number:S 02 ; year:2011 ; pages:E238-E239
Endoscopy ; 43, Heft S 02 (2011), E238-E239
- Contributor
-
Cennamo, V.
Fuccio, L.
Giampalma, E.
Terzi, E.
Eusebi, L. H.
Mosconi, C.
Piscaglia, F.
- DOI
-
10.1055/s-0030-1256512
- URN
-
urn:nbn:de:101:1-2018102211063158112465
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cennamo, V.
- Fuccio, L.
- Giampalma, E.
- Terzi, E.
- Eusebi, L. H.
- Mosconi, C.
- Piscaglia, F.
Other Objects (12)
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
Transarterial Chemoembolization – Status Quo in Germany
Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review
A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)
Transarterial (Chemo-)Embolization and Lipiodolization for Hepatic Haemangioma
Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE)
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma
Combined Transarterial Chemoembolization and Percutaneous Ablation: A Single-Center Experience
Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization
Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
Transarterial Chemoembolization – Status Quo in Germany
Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review
A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)
Transarterial (Chemo-)Embolization and Lipiodolization for Hepatic Haemangioma
Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE)
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma
Combined Transarterial Chemoembolization and Percutaneous Ablation: A Single-Center Experience
Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization
Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
Transarterial Chemoembolization – Status Quo in Germany
Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review
A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)
Transarterial (Chemo-)Embolization and Lipiodolization for Hepatic Haemangioma
Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE)
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma
Combined Transarterial Chemoembolization and Percutaneous Ablation: A Single-Center Experience
Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization